🇺🇸 FDA
Patent

US 7585844

Myosin light chain kinase inhibitors and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 7585844 (Myosin light chain kinase inhibitors and methods of use) held by University College Cardiff Consultants Limited expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P1/04, A61P11/06